arrow-down arrow-left arrow-right check clock edit filter phone question-mark search submit-arrow

Blogs

Welcome to myTomorrows blog, our collection of news, stories and commentaries.

April 12, 2018 - Free Speech

 War on talent: check, check for myTomorrows 

How to attract talents and to ensure digital mindset - Alice Stuurman

War-for-talents-myTomorrows.jpg

March 22, 2018 - Free Speech

Artificial Intelligence can bring humans and robots to work together better

Interviewing Selene Baez Santamaria 

Selene.png

February 28, 2018 - Free Speech

Rare Disease Day 2018

February 28th is Rare Disease Awareness Day. 
One of the most common diseases is the rare disease. This is a paradox.

Rare_Disease_Title.png

February 4, 2018 - Brand

What to do when your cancer won’t wait for a drug approval

Written by Martin Naley, US General Manager at myTomorrows

Martin_Blog_2.png

January 25, 2017 - News

Medicine, new technologies, and the future of rare disease treatments

A conversation with France’s Dr. Laurent Chiche

Laurent_Blog.png

January 16, 2017 - Brand

The Next Step Towards Earlier Access to Drugs in Development

By Dr Ronald Brus, Founder and CEO of myTomorrows

Ronald_Blog_2.png

January 6, 2017 - Brand

How 2016 Changed Early Access and Drug Development

As 2016 has come to an end, it is worth looking back at an eventful year for the biotech and drug development landscape.

2016_Blog.png

December 21, 2016 - News

Rare autoimmune disease specialists shares his experiences

A conversation with Dr. Laurent Chiche

Chiche_Blog.png

November 8, 2016 - Brand

No more options?

When doctors explain to their patients that there are no treatment options left, this often means that there are no drugs available anymore that have been approved for that specific condition and that have been recognized by (inter-)national treatment guidelines. 

Blog_No_more_options.png

June 13, 2016 - Free Speech

Wrapped in Mummy’s Scarf

How children cope with chronically ill parents

Mummy_Blog.png

April 29, 2016 - Brand

Can the price of drugs be justified based on R&D investment?

By Dr Ronald Brus, Founder and CEO of myTomorrows

Ronald_Blog.png